1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX;
2. Department of Haemato-Oncology, King’s College London, London, United Kingdom;
3. Service d’Hématologie Séniors, Hôpital Saint Louis, Université Paris 7, Paris, France;
4. Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada;
5. MDS Unit, AOU Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy;
6. Hematology Department, Institute of Biomedical Research of Salamanca, University Hospital of Salamanca, Salamanca, Spain;
7. IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli” Bologna, Bologna, Italy;
8. Department of Hematology, Ankara University School of Medicine, Ankara, Turkey;
9. Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL;
10. Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT;
11. Bristol Myers Squibb, Princeton, NJ;
12. Acceleron Pharma, Cambridge, MA;
13. Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany; and
14. Moffitt Cancer Center, Tampa, FL